SCHEMBL2996891

SCHEMBL2996891

COC(=O)CCN1C(=O)c2c(N)sc(-c3ccc(OCc4ccccc4)c(OC)c3)c2C1=O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 5/20 0.49
APP P05067 2/20 0.43
AKR1B1 P15121 2/20 0.43
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HSD17B10 Q99714 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
PRKCZ Q05513 1/20 0.42
PTPN1 P18031 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ENPP2 Q13822 2/20 0.41
CTSV O60911 1/20 0.41
CTSL P07711 1/20 0.41
CASP3 P42574 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2997216 0.89 CASP3 (0.42) ALDH1A1MAPTHSD17B10PRKCZRAB9A
SCHEMBL2995635 0.88 ALDH1A1 (0.42) ALDH1A1MAPTHSD17B10PRKCZRAB9A
SCHEMBL2998875 0.86 CASP3 (0.38) ALDH1A1MAPTHSD17B10PRKCZNPC1
SCHEMBL2993087 0.85 ABCB1 (0.48) ABCB1APPAKR1B1ALDH1A1MAPT
SCHEMBL2994385 0.84 ALDH1A1 (0.42) ALDH1A1MAPTHSD17B10PRKCZHPGD
SCHEMBL2994398 0.81 ABCB1 (0.46) ABCB1APPALDH1A1MAPTHSD17B10
SCHEMBL2987999 0.79 PDE4B (0.48)
SCHEMBL2994679 0.72 LMNA (0.44) ALDH1A1MAPTHSD17B10PRKCZRAB9A
SCHEMBL2997644 0.71 TSHR (0.41) ALDH1A1MAPTHSD17B10PRKCZNPC1
SCHEMBL2995869 0.70 LMNA (0.45) ALDH1A1MAPTKDM4CPTPN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100179189-A1 PYRROLINE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR, PREPARATION METHODS AND USES THEREOF ZHANG HESHENG 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179189-A1 PYRROLINE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR, PREPARATION METHODS AND USES THEREOF TNF, IL1B, NOS1 ABCB1 1244/4885APP 3648/4885AKR1B1 674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.